LogicBio Therapeutics (LOGC) Misses Q2 EPS by 23c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Loss before taxes: -143.9K
Today's EPS Names:
PEBK, DIT, AMC, More
EPS Growth %: +82.6%
Financial Fact:
Loss before taxes: -143.9K
Today's EPS Names:
PEBK, DIT, AMC, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q2 EPS of ($0.23).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX sets date for maiden earnings report: Why August 4 is make-or-break
- Steel Dynamics (STLD) Misses Q2 EPS by 7c
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
